Our findings are not restricted to thyroid cancer since HMGA2 has several times been identified as correlating with tumor aggressiveness in other cancers such as breast cancer [54], tongue squamous cell carcinoma [55] and ovarian cancer [56,57], highlighting the common oncogenic role of HMGA2 in tumor progression. Here, HMGA2 is linked to breast carcinoma.